Mechanism of Action
Modulates dopaminergic and serotonergic systems, upregulates BDNF, provides neuroprotection without hormonal (adrenal) side effects. Used clinically in Russia for ischemic stroke since the 1990s.
Clinical Use
Ischemic stroke (Russian standard of care), cognitive enhancement, neuroprotection. Nasal spray administration.
Contraindications
Mania/bipolar disorder (dopaminergic stimulation). Seizure disorders. Hypertension.
Evidence Summary
Approved in Russia for ischemic stroke and cognitive enhancement. 25+ years clinical use. Limited Western peer-reviewed RCTs.
Key Studies
- 1.Multiple Russian clinical trials — standard stroke treatment in Russia for 25+ years. Approved by Russian Ministry of Health
- 2.fMRI validation studies — objective neuroimaging evidence supporting cognitive and neuroprotective effects
Evidence Gaps
Strong Russian clinical history but very limited independent Western RCT validation.
Emerging Research
Growing integrative medicine adoption for cognitive optimization. Post-COVID brain fog applications being explored.